Gerasimos P Sykiotis, Athina Mageiropoulou, Akram Al-Ibraheem, Monica Pinto, Ioannis Iakovou, Arild Andre Østhus, Eva Gamper, Eva Hammerlid, Laura Deborah Locati, Ricardo Ribeiro Gama, Giuseppe Fanetti, Naomi Kiyota, Juan Ignacio Arraras, Johanna Inhestern, Georgios Ioannidis, Rita Canotilho, Olga Husson, Guy Andry, Harald Rimmele, Matthias Buettner, Katherine J Taylor, Susanne Singer
{"title":"分化型甲状腺癌患者情绪功能不良的前瞻性预测因素。","authors":"Gerasimos P Sykiotis, Athina Mageiropoulou, Akram Al-Ibraheem, Monica Pinto, Ioannis Iakovou, Arild Andre Østhus, Eva Gamper, Eva Hammerlid, Laura Deborah Locati, Ricardo Ribeiro Gama, Giuseppe Fanetti, Naomi Kiyota, Juan Ignacio Arraras, Johanna Inhestern, Georgios Ioannidis, Rita Canotilho, Olga Husson, Guy Andry, Harald Rimmele, Matthias Buettner, Katherine J Taylor, Susanne Singer","doi":"10.1177/10507256261442504","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The health-related quality of life (HRQoL) of patients with differentiated thyroid carcinoma (DTC), especially their mental health, can be compromised by various factors beyond disease prognosis and treatment stage. However, predictors of poor emotional functioning (EF) in DTC patients have not been thoroughly studied. To inform targeted interventions that could improve or preserve HRQoL in patients with DTC, this study aimed to identify predictors of impaired EF, and particularly modifiable factors.</p><p><strong>Methods: </strong>Data analyzed were from the phase IV international validation study of the European Organization for Research and Treatment of Cancer thyroid cancer-specific HRQoL questionnaire (QLQ-THY34). Patients (<i>n</i> = 196) were assessed at three timepoints before treatment (t1), 6 weeks after the start of treatment (t2), and 6 months after t2 (t3). Multilevel, multivariable logistic regression models were used to assess the likelihood of impaired EF at t3 according to predefined potential predictors at t1 and t2.</p><p><strong>Results: </strong>Impaired EF at t1 or t2 predicted impaired EF at t3. Exhaustion, head and neck discomfort and body image issues were significantly associated with poor EF at t3. More specifically, temporal changes of these three variables from t1 to t2 were independent predictors of poor EF at t3 with an odds ratio of 1.04 (<i>p</i> < 0.001), 1.01 (<i>p</i> = 0.04), and 1.01 (<i>p</i> = 0.001) per score point, respectively. There was no evidence that worry about important others, lacking social support, sex, stage, or Karnofsky performance score are associated with EF at t3.</p><p><strong>Conclusions: </strong>Exhaustion, head and neck discomfort, and body image concerns emerged as modifiable factors that predict future impaired EF in patients with DTC undergoing treatment. These factors could be targeted in prehabilitation, rehabilitation or other interventional programs to potentially improve or preserve patients' EF.</p>","PeriodicalId":23016,"journal":{"name":"Thyroid","volume":" ","pages":"10507256261442504"},"PeriodicalIF":6.7000,"publicationDate":"2026-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prospective Predictors of Poor Emotional Functioning in Patients with Differentiated Thyroid Carcinoma.\",\"authors\":\"Gerasimos P Sykiotis, Athina Mageiropoulou, Akram Al-Ibraheem, Monica Pinto, Ioannis Iakovou, Arild Andre Østhus, Eva Gamper, Eva Hammerlid, Laura Deborah Locati, Ricardo Ribeiro Gama, Giuseppe Fanetti, Naomi Kiyota, Juan Ignacio Arraras, Johanna Inhestern, Georgios Ioannidis, Rita Canotilho, Olga Husson, Guy Andry, Harald Rimmele, Matthias Buettner, Katherine J Taylor, Susanne Singer\",\"doi\":\"10.1177/10507256261442504\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The health-related quality of life (HRQoL) of patients with differentiated thyroid carcinoma (DTC), especially their mental health, can be compromised by various factors beyond disease prognosis and treatment stage. However, predictors of poor emotional functioning (EF) in DTC patients have not been thoroughly studied. To inform targeted interventions that could improve or preserve HRQoL in patients with DTC, this study aimed to identify predictors of impaired EF, and particularly modifiable factors.</p><p><strong>Methods: </strong>Data analyzed were from the phase IV international validation study of the European Organization for Research and Treatment of Cancer thyroid cancer-specific HRQoL questionnaire (QLQ-THY34). Patients (<i>n</i> = 196) were assessed at three timepoints before treatment (t1), 6 weeks after the start of treatment (t2), and 6 months after t2 (t3). Multilevel, multivariable logistic regression models were used to assess the likelihood of impaired EF at t3 according to predefined potential predictors at t1 and t2.</p><p><strong>Results: </strong>Impaired EF at t1 or t2 predicted impaired EF at t3. Exhaustion, head and neck discomfort and body image issues were significantly associated with poor EF at t3. More specifically, temporal changes of these three variables from t1 to t2 were independent predictors of poor EF at t3 with an odds ratio of 1.04 (<i>p</i> < 0.001), 1.01 (<i>p</i> = 0.04), and 1.01 (<i>p</i> = 0.001) per score point, respectively. There was no evidence that worry about important others, lacking social support, sex, stage, or Karnofsky performance score are associated with EF at t3.</p><p><strong>Conclusions: </strong>Exhaustion, head and neck discomfort, and body image concerns emerged as modifiable factors that predict future impaired EF in patients with DTC undergoing treatment. These factors could be targeted in prehabilitation, rehabilitation or other interventional programs to potentially improve or preserve patients' EF.</p>\",\"PeriodicalId\":23016,\"journal\":{\"name\":\"Thyroid\",\"volume\":\" \",\"pages\":\"10507256261442504\"},\"PeriodicalIF\":6.7000,\"publicationDate\":\"2026-04-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Thyroid\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/10507256261442504\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thyroid","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10507256261442504","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
背景:分化型甲状腺癌(DTC)患者的健康相关生活质量(HRQoL),尤其是心理健康,可能受到疾病预后和治疗阶段以外的多种因素的影响。然而,DTC患者情绪功能不良的预测因素尚未得到深入研究。为了提高或保持DTC患者HRQoL的针对性干预措施,本研究旨在确定EF受损的预测因素,特别是可改变的因素。方法:数据分析来自欧洲癌症研究与治疗组织甲状腺癌特异性HRQoL问卷(QLQ-THY34)的IV期国际验证研究。在治疗前(t1)、治疗开始后6周(t2)和治疗后6个月(t3)三个时间点对患者(n = 196)进行评估。采用多水平、多变量逻辑回归模型,根据预先定义的t1和t2的潜在预测因子,评估t3时EF受损的可能性。结果:EF at t1或t2损伤可预测EF at t3损伤。疲劳、头颈部不适和身体形象问题与不良的EF t3显著相关。更具体地说,这三个变量从t1到t2的时间变化是t3时不良EF的独立预测因子,比值比分别为1.04 (p < 0.001)、1.01 (p = 0.04)和1.01 (p = 0.001) /分。没有证据表明担心重要的他人、缺乏社会支持、性别、阶段或Karnofsky表现分数与EF at t3有关。结论:疲劳、头颈部不适和对身体形象的担忧是预测接受治疗的DTC患者未来EF受损的可改变因素。这些因素可以作为预防、康复或其他干预项目的目标,以潜在地改善或保持患者的EF。
Prospective Predictors of Poor Emotional Functioning in Patients with Differentiated Thyroid Carcinoma.
Background: The health-related quality of life (HRQoL) of patients with differentiated thyroid carcinoma (DTC), especially their mental health, can be compromised by various factors beyond disease prognosis and treatment stage. However, predictors of poor emotional functioning (EF) in DTC patients have not been thoroughly studied. To inform targeted interventions that could improve or preserve HRQoL in patients with DTC, this study aimed to identify predictors of impaired EF, and particularly modifiable factors.
Methods: Data analyzed were from the phase IV international validation study of the European Organization for Research and Treatment of Cancer thyroid cancer-specific HRQoL questionnaire (QLQ-THY34). Patients (n = 196) were assessed at three timepoints before treatment (t1), 6 weeks after the start of treatment (t2), and 6 months after t2 (t3). Multilevel, multivariable logistic regression models were used to assess the likelihood of impaired EF at t3 according to predefined potential predictors at t1 and t2.
Results: Impaired EF at t1 or t2 predicted impaired EF at t3. Exhaustion, head and neck discomfort and body image issues were significantly associated with poor EF at t3. More specifically, temporal changes of these three variables from t1 to t2 were independent predictors of poor EF at t3 with an odds ratio of 1.04 (p < 0.001), 1.01 (p = 0.04), and 1.01 (p = 0.001) per score point, respectively. There was no evidence that worry about important others, lacking social support, sex, stage, or Karnofsky performance score are associated with EF at t3.
Conclusions: Exhaustion, head and neck discomfort, and body image concerns emerged as modifiable factors that predict future impaired EF in patients with DTC undergoing treatment. These factors could be targeted in prehabilitation, rehabilitation or other interventional programs to potentially improve or preserve patients' EF.
期刊介绍:
This authoritative journal program, including the monthly flagship journal Thyroid, Clinical Thyroidology® (monthly), and VideoEndocrinology™ (quarterly), delivers in-depth coverage on topics from clinical application and primary care, to the latest advances in diagnostic imaging and surgical techniques and technologies, designed to optimize patient care and outcomes.
Thyroid is the leading, peer-reviewed resource for original articles, patient-focused reports, and translational research on thyroid cancer and all thyroid related diseases. The Journal delivers the latest findings on topics from primary care to clinical application, and is the exclusive source for the authoritative and updated American Thyroid Association (ATA) Guidelines for Managing Thyroid Disease.